| 5.625 0.095 (1.72%) | 04-17 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 8.44  |
1-year : | 9.69 |
| Resists | First : | 7.23 |
Second : | 8.3 |
| Pivot price | 6.53 |
|||
| Supports | First : | 5.51 | Second : | 4.58 |
| MAs | MA(5) : | 5.86 |
MA(20) : | 6.84 |
| MA(100) : | 8.54 |
MA(250) : | 9.97 |
|
| MACD | MACD : | -0.7 |
Signal : | -0.6 |
| %K %D | K(14,3) : | 2.4  |
D(3) : | 3.9 |
| RSI | RSI(14): 24.4 |
|||
| 52-week | High : | 14.36 | Low : | 5.51 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ HCAT ] has closed above bottom band by 12.6%. Bollinger Bands are 18.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 5.73 - 5.77 | 5.77 - 5.8 |
| Low: | 5.43 - 5.47 | 5.47 - 5.51 |
| Close: | 5.56 - 5.62 | 5.62 - 5.68 |
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accuracy; population health management identifies improvement across the care continuum as well as actionable guidance for success and automated workflows; financial transformation providing costing and labor productivity insights and revenue capture; quality and safety improvement using clinical quality and patient safety data, analytics, and expert services; and national data ecosystem for thought leadership and mutual knowledge exchange to transform care delivery through next-gen insights. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is based in South Jordan, Utah.
Thu, 18 Apr 2024
Health Catalyst executive sells over $12000 in company stock - Investing.com South Africa
Wed, 17 Apr 2024
Perigon Wealth Management LLC Raises Position in Health Catalyst, Inc. (NASDAQ:HCAT) - Defense World
Tue, 16 Apr 2024
Health Catalyst Reports Fourth Quarter and Year End 2021 Results - The Globe and Mail
Tue, 16 Apr 2024
Health Catalyst to Participate in Upcoming Investor Conferences - The Globe and Mail
Fri, 12 Apr 2024
Health Catalyst (NASDAQ:HCAT) Stock Rating Reaffirmed by KeyCorp - Defense World
Thu, 04 Apr 2024
Benign Growth For Health Catalyst, Inc. (NASDAQ:HCAT) Underpins Its Share Price - Simply Wall St
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 59 (M) |
| Shares Float | 53 (M) |
| Held by Insiders | 3.5 (%) |
| Held by Institutions | 88.8 (%) |
| Shares Short | 1,520 (K) |
| Shares Short P.Month | 1,710 (K) |
| EPS | -2.09 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 6.28 |
| Profit Margin | -40 % |
| Operating Margin | -29.3 % |
| Return on Assets (ttm) | -7.5 % |
| Return on Equity (ttm) | -29.9 % |
| Qtrly Rev. Growth | 8.6 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 5.05 |
| EBITDA (p.s.) | -0.91 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -33 (M) |
| Levered Free Cash Flow | 22 (M) |
| PE Ratio | -2.7 |
| PEG Ratio | 0 |
| Price to Book value | 0.89 |
| Price to Sales | 1.11 |
| Price to Cash Flow | -9.96 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|